Post-stroke treatment with K-134, a phosphodiesterase 3 inhibitor, improves stroke outcomes in the stroke-prone spontaneously hypertensive rat model-A comparative evaluation of antiplatelet drugs

• Main Authors: Hideo Yoshida (Author), Shinsuke Itoh (Author), Farhana Ferdousi (Author), Hiroko Isoda (Author)
• Formato: Livro
• Publicado em: Elsevier, 2022-02-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Post-stroke antiplatelet therapy has been proved to reduce the risk of recurrent stroke; however, it may also increase the incidence of intracranial hemorrhage that could offset any benefits. Therefore, the balance between the benefits and risks of antiplatelet drugs is a critical issue to consider....